Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|June 24, 2013
- June 2013
- Volume 17
- Issue 1
Acetaminophen Helps Death Fears
Advertisement
Acetaminophen may be able to treat fear and anxiety of death, according to a study published online on April 11, 2013, by Psychological Science. Participants were given acetaminophen or a placebo while completing activities designed to create feelings of existential dread, such as writing about death. Those who took acetaminophen were less anxious than the placebo group.
Articles in this issue
over 13 years ago
Pain Control: Using Nonprescription Analgesicsover 13 years ago
US-Born Children Have More Asthma, Allergies Than Immigrant Peersover 13 years ago
Finding Effective Relief for Constipationover 13 years ago
Multiple Factors Linked to Readmission After GI Surgeryover 13 years ago
Case Studies in Self-Careover 13 years ago
Multivitamin/Multimineral Supplement Useover 13 years ago
2012-2013 The Medical Year in Reviewover 13 years ago
Pharmacy Times: Leading the Wayover 13 years ago
Activity Helps Hot Flashes & Night Sweatsover 13 years ago
Weight Gain During Pregnancy Increases Laceration RiskAdvertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
3
Alcohol and GLP-1 Therapy: Key Counseling Points for Pharmacists
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5